loading

Finanzdaten der Replimune Group Inc-Aktie (REPL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-10-01 2024-07-01
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
13.98%
90.42
79.33 66.02 - -
Operating Income/Loss
13.98%
-90.42
-79.33 -66.02 - -
Nonoperating Income/Loss
26.75%
3.729
5.091 0.254 - -
Income/Loss From Continuing Operations Before Tax
16.78%
-86.69
-74.24 -65.77 -53.05 -53.77
Income Tax Expense/Benefit
100.00%
-
-0.107 0.575 - -
Income/Loss From Continuing Operations After Tax
17.69%
-86.69
-73.66 -66.34 -53.05 -53.77
Net Income/Loss
16.95%
-86.69
-74.13 -66.34 -53.05 -53.77
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,552%
91.52
3.4505 83.50 - -
Diluted Average Shares
2,552%
91.52
3.4505 83.50 - -
Basic Earnings Per Share
15.85%
-0.95
-0.82 -0.79 - -
Diluted Earnings Per Share
15.85%
-0.95
-0.82 -0.79 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):